Vipul Organics Q1 Results: Net profit up 100% YoY to ₹252 lakh
Vipul Organics Ltd delivered robust Q1FY27 results, with net profit surging 99.75% YoY to ₹252.46 lakh and revenues climbing 38.44% to ₹5,217.52 lakh. Profit before tax jumped 113%, reflecting effective cost optimization. Quarter-on-quarter, revenues were flat while profits rose, signaling improved margins. Management highlighted the completion of capex cycles and upcoming contributions from the membrane division as key growth drivers.

*this image is generated using AI for illustrative purposes only.
Vipul Organics Limited reported a significant improvement in profitability for the first quarter of FY27, with consolidated net profit after tax (PAT) rising 99.75% year-on-year to ₹252.46 lakh. The specialty chemicals company posted total revenues of ₹5,217.52 lakh, marking a 38.44% increase from the ₹3,768.81 lakh recorded in Q1FY26.
Profit before tax (PBT) expanded sharply by 113% to ₹344.62 lakh, outpacing the revenue growth and indicating improved operational efficiency. Earnings per share (EPS) grew 54.65% to ₹1.33 from ₹0.86 in the corresponding period last year.
Quarterly Performance
On a quarter-on-quarter basis, revenues remained relatively stable, declining marginally by 0.85% from ₹5,262.38 lakh in Q4FY26. However, profitability metrics showed consistent upward momentum. PBT rose 14.53% to ₹344.47 lakh, while PAT increased 27.93% to ₹252.46 lakh compared to the previous quarter.
| Metric: | Q1FY27 | Q1FY26 | YoY Change |
|---|---|---|---|
| Total Revenue: | ₹5,217.52 lakh | ₹3,768.81 lakh | +38.44% |
| PBT: | ₹344.62 lakh | ₹161.72 lakh | +113% |
| PAT: | ₹252.46 lakh | ₹126.39 lakh | +99.75% |
| EPS: | ₹1.33 | ₹0.86 | +54.65% |
What the Numbers Show
The divergence between revenue growth and profit expansion highlights strong operating leverage. While revenues grew by 38.44%, profit before tax more than doubled with a 113% increase. This suggests that cost optimization initiatives are yielding immediate results, allowing a larger portion of incremental revenue to flow through to the bottom line. The company’s management noted that these efforts are beginning to translate into margin expansion.
Management Outlook
Vipul P. Shah, Managing Director, attributed the results to the continued strength of core businesses and progress in diversification. He stated that the current capital expenditure cycle is now complete, positioning the company for sustained growth. Additionally, the membrane division remains on track to add a new visible revenue stream in the coming quarters. The company is also finalizing its internal multi-decadal roadmap, Vision 2035, which will be shared with shareholders in due course.
Historical Stock Returns for Vipul Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.86% | +0.53% | -0.82% | +16.62% | +9.28% | +117.11% |
How will the completion of the current capital expenditure cycle impact Vipul Organics' free cash flow and debt levels in the near term?
What specific revenue contribution is expected from the membrane division in the upcoming quarters, and how will it affect overall margin profiles?
Can you elaborate on the key strategic pillars of the 'Vision 2035' roadmap and how they align with emerging trends in the specialty chemicals sector?


































